A Day In FDA Supplement Industry Regulation: Track Spiked Product, Oversee Court-Ordered Recall
This article was originally published in The Tan Sheet
Executive Summary
FDA identifies a product marketed as a supplement but labeled as containing anabolic steroids and linked to three adverse event reports about “serious liver injury,” and also notes the recall of nearly 150 supplements by a firm shut down in a consent decree made after repeated GMP violations.